Impact of treatment on survival of patients with secondary glioblastoma-Reference-Cited by-同舟云学术

Impact of treatment on survival of patients with secondary glioblastoma

Published:2017-05-30 Issue:2 Volume:133 Page:309-313
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Hamisch Christina,Ruge Maximilian,Kellermann Stephanie,Kohl Ann-Cathrin,Duval Inga,Goldbrunner Roland,Grau Stefan J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/article/10.1007/s11060-017-2415-y/fulltext.html

Reference11 articles.

1. Ohgaki H, Kleihues P (2013) The definition of primary and secondary glioblastoma. Clin Cancer Res 19:764–772. doi: 10.1158/1078-0432.CCR-12-3002

2. Nobusawa S, Watanabe T, Kleihues P, Ohgaki H (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15:6002–6007. doi: 10.1158/1078-0432.CCR-09-0715

3. Juratli TA, Kirsch M, Geiger K et al (2012) The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas. J Neurooncol 110:325–333. doi: 10.1007/s11060-012-0977-2

4. McCormack BM, Miller DC, Budzilovich GN et al (1992) Treatment and survival of low-grade astrocytoma in adults–1977–1988. Neurosurgery 31:636–642 (discussion 642)

5. Ramakrishna R, Hebb A, Barber J et al (2015) Outcomes in Reoperated Low-Grade Gliomas. Neurosurgery 77:175–184. doi: 10.1227/NEU.0000000000000753

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time-to-event overall survival prediction in glioblastoma multiforme patients using magnetic resonance imaging radiomics;La radiologia medica;2023-09-26

2. Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018;Journal of Neuro-Oncology;2023-09

3. The Impact of ioMRI on Glioblastoma Resection and Clinical Outcomes in a State-of-the-Art Neuro-Oncological Setup;Cancers;2023-07-10

4. Prognostic and predictive factors of secondary gliosarcoma: A single-institution series of 18 cases combined with 89 cases from literature;Frontiers in Oncology;2023-01-31

5. Identification of serum exosomal miR-98–5p, miR-183–5p, miR-323–3p and miR-19b-3p as potential biomarkers for glioblastoma patients and investigation of their mechanisms;Current Research in Translational Medicine;2022-01